Unicycive Therapeutics faces securities class action over NDA statements
The suit was filed Sept. 3, 2026 in U.S. District Court for the Northern District of California. Unicycive said the allegations are meritless and plans to fight the case.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.